Basic information
- CAS
623142-96-1- Standard SMILES
COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1- InChIKey
SHPFDGWALWEPGS-UHFFFAOYSA-N- Molecular formula
- C24H24N4O5S
- Average molar mass
- 480.5 g/mol
- Monoisotopic mass
- 480.14674105
Names & identifiers
- Preferred name
- Ki-20227
- IUPAC
- 1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2-methoxyphenyl]-3-[1-(1,3-thiazol-2-yl)ethyl]urea
- English name
- N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea
- Molecular formula
- C24H24N4O5S
- Molecular weight
- 480.54
Names & synonyms
Show more names
Database identifiers
- CAS
623142-96-1- PubChem CID
- 9869779
- DTXSID
DTXSID80432108- ChEMBL
CHEMBL1908396- UNII
- T4W68CAT3P
- Nikkaji
- J2.851.477H
Properties
Computed structural properties
- XLogP
- 3.6
- Topological polar surface area
- 132 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 8
- Rotatable bonds
- 8
- Heavy atoms
- 34
- Formal charge
- 0
- Complexity
- 661
Physicochemical properties
- Boiling point
- 621.8 · 621.8±55.0 °C(Predicted)
- Density
- 1.327 · 1.327
- storage temp.
- -20 °C · Sealed in dry,Store in freezer, under -20°C
- solubility
- 48.1 mg/mL · ≥48.1 mg/mL in DMSO; insoluble in H2O; ≥8.6 mg/mL in EtOH with gentle warming and ultrasonic
- form
- Brown powder.
- pka
- 12.03 · 12.03±0.46(Predicted)
- color
- Off-white to pink
- FDA UNII
- 4 W68CAT3P · T4W68CAT3P
Chemistry & industry
Applications
DescriptionKi20227 is an inhibitor of macrophage colony stimulating factor 1 (CSF1) receptor tyrosine kinase (c-Fms; IC50 = 2 nM). It inhibits CSF1-dependent c-Fms phosphorylation in a dose-dependent manner in RAW264.7 cells and reduces CSF1-dependent growth of M-NFS-60 cells (IC50 = 14 nM). Ki20227 suppresses development of TRAP-positive osteoclast-like cells from murine bone marrow (IC50 = 40 nM) and decreases the number and area of osteolytic lesions on femurs and tibiae in a murine A375 subcutaneous xenograft model. Ki20227 also reduces TNF-α infiltration and osteolytic bone destruction in a collagen-induced arthritis (CIA) mouse model.
UsesKi 20227 is a c-fms tyrosine kinase inhibitor, which suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
Suppliers80 total
Related reactions
Compound notes
Loading…